{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:16:22Z","timestamp":1790712982211,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Co-trimoxazole could be an alternative antibiotic to treat device-related bone and joint infection (BJI) but there are few published data about its efficacy and safety in this complex scenario to treat infection. The objective was to compare the outcome of patients with device-related BJI treated with an antibiotic regimen including co-trimoxazole versus a regimen without co-trimoxazole.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This multicentre case\u2013control study included consecutive adult patients diagnosed with device-related BJI. Each patient receiving co-trimoxazole was included in the co-trimoxazole group and was matched with two control patients, with stratification on microbial aetiology and age. The primary outcome was composite and defined by death or treatment failure during the follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In this study, 150 patients were included, 50 in the co-trimoxazole group and 100 in the control group. The rate of reaching the primary endpoint was 18% in the co-trimoxazole group (9\/50 cases) versus 21% in the control group (21\/100) (P\u200a=\u200a0.66). Co-trimoxazole use was not associated with an unfavourable outcome in the multivariate analysis (adjusted OR 0.8, 95% CI 0.31\u20132.06, P\u200a=\u200a0.64). Although no significant difference was observed in premature discontinuation of treatment due to an adverse event between both groups (14 versus 12%, P\u200a=\u200a0.73), treatment-related adverse events were significantly more frequently reported in patients of the co-trimoxazole group than the control group [34% (17\/50) versus 18% (18\/100), P\u200a=\u200a0.03].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Co-trimoxazole appears to be an effective alternative for the treatment of BJI, even when it occurs on a device, but the safety profile requires close monitoring of adverse effects.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkae328","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T05:46:00Z","timestamp":1726206360000},"page":"3109-3115","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of co-trimoxazole in device-related bone and joint infections: a CRIOGO multicentre case\u2013control study"],"prefix":"10.1093","volume":"79","author":[{"given":"Rapha\u00ebl","family":"Lecomte","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, CHU H\u00f4tel-Dieu , Nantes ,","place":["France"]},{"name":"Centre d\u2019Investigation Clinique, Unit\u00e9 d\u2019Investigation Clinique 1413 INSERM , CHU Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1133-5207","authenticated-orcid":false,"given":"Colin","family":"Deschanvres","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, CHU H\u00f4tel-Dieu , Nantes ,","place":["France"]},{"name":"Centre d\u2019Investigation Clinique, Unit\u00e9 d\u2019Investigation Clinique 1413 INSERM , CHU Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Le Bourgeois","sequence":"additional","affiliation":[{"name":"Department of Hematology, CHU H\u00f4tel-Dieu , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Bart","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Internal Medicine, Percy Military Training Hospital , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u00ebl","family":"Mahieu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, CHU Angers , Angers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9na\u00ebl","family":"Le Moal","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, CHU de Poitiers , Poitiers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Ansart","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, CHU Brest , Brest ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Asseray","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, CHU H\u00f4tel-Dieu , Nantes ,","place":["France"]},{"name":"Centre d\u2019Investigation Clinique, Unit\u00e9 d\u2019Investigation Clinique 1413 INSERM , CHU Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Ruffier d\u2019Epenoux","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, CHU Nantes , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-8111","authenticated-orcid":false,"given":"St\u00e9phane","family":"Corvec","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, CHU Nantes , Nantes ,","place":["France"]},{"name":"INSERM, INCIT U1302, Universit\u00e9 de Nantes, CHU Nantes , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-2029","authenticated-orcid":false,"given":"David","family":"Boutoille","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, CHU H\u00f4tel-Dieu , Nantes ,","place":["France"]},{"name":"Centre d\u2019Investigation Clinique, Unit\u00e9 d\u2019Investigation Clinique 1413 INSERM , CHU Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CRIOGO network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Abgueguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Caubri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Lemarie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Chenouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Pailhories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Vildy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Ansart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Quaesaet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Stindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Tand\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudie","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Greves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Deschanvres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Asquier-Khati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gaborit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Nich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Crenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"B\u00e9mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Corvec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Ruffier","family":"d\u2019Epenoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Paquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bourigault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Plantard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Cazenave-Roblot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00ebl Le","family":"Moal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Plouzeau-Jayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Arvieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Baldeyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Common","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cattoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Reissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"M\u00e9heut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Lemaignen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Lacasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Rom\u00e9e Le","family":"Nail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fr\u00e9d\u00e9rique","family":"Lartigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Laplaige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Chaufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"2024121304521802000_dkae328-B1","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"key":"2024121304521802000_dkae328-B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cis966","article-title":"Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024121304521802000_dkae328-B3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1302\/0301-620X.95B11.33135","article-title":"Proceedings of the International Consensus on Periprosthetic Joint Infection","volume":"95-B","author":"Parvizi","year":"2013","journal-title":"Bone Jt J"},{"key":"2024121304521802000_dkae328-B4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/cid\/cir402","article-title":"Outcome and predictors of treatment failure in total hip\/knee prosthetic joint infections due to Staphylococcus aureus","volume":"53","author":"Senneville","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024121304521802000_dkae328-B5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2165\/11587280-000000000-00000","article-title":"Quinolones: review of psychiatric and neurological adverse reactions","volume":"34","author":"Tom\u00e9","year":"2011","journal-title":"Drug Saf"},{"key":"2024121304521802000_dkae328-B6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.otsr.2013.02.011","article-title":"Bacterial epidemiology of osteoarticular infections in a referent center: 10-year study","volume":"99","author":"Tit\u00e9cat","year":"2013","journal-title":"Orthop Traumatol Surg Res"},{"key":"2024121304521802000_dkae328-B7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1592\/phco.25.2.253.56956","article-title":"Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus","volume":"25","author":"Grim","year":"2005","journal-title":"Pharmacotherapy"},{"key":"2024121304521802000_dkae328-B8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1469-0691.2009.02701.x","article-title":"Management of methicillin-resistant Staphylococcus aureus infections","volume":"15","author":"Garau","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2024121304521802000_dkae328-B9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jac\/dkl283","article-title":"Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus","volume":"58","author":"Kaka","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2024121304521802000_dkae328-B10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/jac\/dkl017","article-title":"Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK","volume":"57","author":"Gemmell","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2024121304521802000_dkae328-B11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/jac\/dku352","article-title":"Randomized non-inferiority trial to compare trimethoprim\/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection","volume":"70","author":"Harbarth","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2024121304521802000_dkae328-B12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/j.1469-0691.2009.02761.x","article-title":"Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections","volume":"15","author":"Nguyen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2024121304521802000_dkae328-B13","doi-asserted-by":"publisher","first-page":"e0224106","DOI":"10.1371\/journal.pone.0224106","article-title":"Efficacy of cotrimoxazole (sulfamethoxazole-trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)","volume":"14","author":"Deconinck","year":"2019","journal-title":"PLoS One"},{"key":"2024121304521802000_dkae328-B14","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1128\/AAC.01504-08","article-title":"Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis","volume":"53","author":"Euba","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2024121304521802000_dkae328-B15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1302\/2046-3758.910.BJR-2019-0362.R1","article-title":"Computerized registry as a potential tool for surveillance and management of complex bone and joint infections in France: French registry of complex bone and joint infections","volume":"9","author":"Lemaignen","year":"2020","journal-title":"Bone Jt Res"},{"key":"2024121304521802000_dkae328-B16","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024121304521802000_dkae328-B17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024121304521802000_dkae328-B18","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1128\/AAC.45.11.3238-3241.2001","article-title":"Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients","volume":"45","author":"Ribera","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2024121304521802000_dkae328-B19","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/jac\/dkv481","article-title":"Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention","volume":"71","author":"Tornero","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2024121304521802000_dkae328-B20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jinf.2015.03.013","article-title":"Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination","volume":"71","author":"Bernard","year":"2015","journal-title":"J Infect"},{"key":"2024121304521802000_dkae328-B21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12879-017-2429-2","article-title":"Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study","volume":"17","author":"Leijtens","year":"2017","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/12\/3109\/60930176\/dkae328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/12\/3109\/60930176\/dkae328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T04:52:27Z","timestamp":1734065547000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/79\/12\/3109\/7759343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":21,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,9,17]]},"published-print":{"date-parts":[[2024,12,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae328","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,9,17]]}}}